Advanced Biomed (ADVB) Enterprise Value (2023 - 2026)

Advanced Biomed has reported Enterprise Value for 4 years, with the latest figure at -$2.6 million in Q1 2026.

• Quarterly Enterprise Value rose 17.75% year-over-year to -$2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.6 million (up 17.75% YoY) and the FY2025 annual result came in at -$2.9 million, down 10.01% from the prior year.
• Enterprise Value was little changed at -$2.6 million in Q1 2026 per ADVB's latest filing, from -$2.6 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$9579.0 in Q4 2024 and troughed at -$3.2 million in Q1 2025.
• A 4-year average of -$2.5 million and a median of -$2.7 million in 2024 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 99.66% in 2024, then tumbled 27228.18% in 2025.
• Over 4 years, Enterprise Value stood at -$2.8 million in 2023, then soared by 99.66% to -$9579.0 in 2024, then sank by 27228.18% to -$2.6 million in 2025, then climbed by 0.19% to -$2.6 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$2.6 million, -$2.6 million, and -$2.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.